Researchers sought to determine whether detecting MRD with mutational analysis and FCM may aid in predicting disease progression following myeloablative allo-HSCT in patients with MDS.
Researchers sought to develop a model for busulfan dosing in pediatric patients receiving HSCT.
The American Society of Hematology recently released 2021 guidelines for hematopoietic stem cell transplantation for patients with sickle cell disease.
Researchers sought to determine whether allo-HSCT would negate poorer outcomes in patients with MDS who have myelofibrosis.
Researchers identified areas of improved outcomes for patients receiving allogeneic blood or marrow transplantation as well as some areas of concern.
Researchers sought to determine whether Ba levels after allo-HSCT may serve as a prognostic biomarker of transplant-associated thrombotic microangiopathy.
Researchers sought to determine whether omidubicel may improve neutrophil and platelet recovery in patients receiving standard myeloablative umbilical cord blood transplantation.
Researchers sought to determine if treatment with PTCy is safe for patients with hematologic malignancies in the HLA-haploidentical setting.
Researchers sought to determine whether panobinostat may help to prevent GVHD in patients who receive stem cell transplant with matched donors.
Researchers sought to determine whether letermovir may delay cytomegalovirus-specific cellular reconstitution for patients undergoing HCT.
